Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective-Reference-Cited by-同舟云学术

Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective

Published:2019-12-16 Issue:1 Volume:35 Page:19-29
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Saito Yuichi,Kobayashi Yoshio,Tanabe Kengo,Ikari Yuji

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12928-019-00633-6.pdf

Reference76 articles.

1. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665–71.

2. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084–9.

3. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2016;68:1082–115.

4. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60.

5. JCS 2018 Guideline on Revascularization of Stable Coronary Artery Disease. http://www.j-circ.or.jp/guideline/pdf/JCS2018_nakamura_yaku.pdf. Accessed 6 Dec 2019.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22;European Heart Journal - Quality of Care and Clinical Outcomes;2024-08-08

2. Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry;Cardiovascular Intervention and Therapeutics;2024-02-13

3. Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel;Journal of Atherosclerosis and Thrombosis;2023-12-01

4. Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis;International Journal of Cardiology;2023-10

5. Stroke risk related to intentional discontinuation of antithrombotic therapy for invasive procedures;Neurosurgical Focus;2023-10